(Q71121091)
Statements
Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial (English)
L Dogliotti
A Berruti
T Buniva
P Zola
M G Baù
A Farris
M G Sarobba
A Bottini
P Alquati
F Deltetto
P Gosso
C Monzeglio
G Moro
M Sussio